Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 MicroRNAs networks in thyroid cancers: focus on miRNAs related to the fascin.

Literature DB >> 23815851

MicroRNAs networks in thyroid cancers: focus on miRNAs related to the fascin.

Hilda Samimi¹, Majid Zaki Dizaji, Mohsen Ghadami, Abolhasan Shahzadeh Fazeli, Patricia Khashayar, Masoud Soleimani, Bagher Larijani, Vahid Haghpanah.

Abstract

miRNAs are non coding ribonucleic acids which are protected with respect to evolution, and have a length of 18-25 nucleotides. microRNAs control the gene expression after transcription, through mRNA destruction or translation processing, and therefore participate in arrangement of the physiologic and pathologic cellular processes; They also may act as oncogene or tumor suppressors. Altered expression of a number of microRNAs is reported in process of progression and metastasis of thyroid cancers. Therefore, identification of these microRNAs may shed a light to oncogenesis pathway of thyroid cancers and their metastasis. In addition, microRNAs might apply as potential biological markers in diagnosis and treatment of thyroid cancers. The changes made in miRNAs profile of thyroid cancers are reviewed in this paper.

Entities: Chemical Disease Gene Species

Year: 2013 PMID： 23815851 PMCID： PMC7976609 DOI： 10.1186/2251-6581-12-31

Source DB: PubMed Journal: J Diabetes Metab Disord ISSN： 2251-6581

46 in total

1. A pooled analysis of thyroid cancer studies. V. Anthropometric factors.

Authors: L Dal Maso; C La Vecchia; S Franceschi; S Preston-Martin; E Ron; F Levi; W Mack; S D Mark; A McTiernan; L Kolonel; K Mabuchi; F Jin; G Wingren; M R Galanti; A Hallquist; E Glattre; E Lund; D Linos; E Negri
Journal: Cancer Causes Control Date: 2000-02 Impact factor: 2.506

2. AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. American Association of Clinical Endocrinologists. American College of Endocrinology.

Authors: R H Cobin; H Gharib; D A Bergman; O H Clark; D S Cooper; G H Daniels; R A Dickey; D S Duick; J R Garber; I D Hay; J S Kukora; H M Lando; A B Schorr; M A Zeiger
Journal: Endocr Pract Date: 2001 May-Jun Impact factor: 3.443

3. The role of microRNA genes in papillary thyroid carcinoma.

Authors: Huiling He; Krystian Jazdzewski; Wei Li; Sandya Liyanarachchi; Rebecca Nagy; Stefano Volinia; George A Calin; Chang-Gong Liu; Kaarle Franssila; Saul Suster; Richard T Kloos; Carlo M Croce; Albert de la Chapelle
Journal: Proc Natl Acad Sci U S A Date: 2005-12-19 Impact factor: 11.205

4. RAS is regulated by the let-7 microRNA family.

Authors: Steven M Johnson; Helge Grosshans; Jaclyn Shingara; Mike Byrom; Rich Jarvis; Angie Cheng; Emmanuel Labourier; Kristy L Reinert; David Brown; Frank J Slack
Journal: Cell Date: 2005-03-11 Impact factor: 41.582

Review 5. microRNA and cancer.

Authors: Mengfeng Li; Jun Li; Xiaofan Ding; Mian He; Shi-Yuan Cheng
Journal: AAPS J Date: 2010-04-28 Impact factor: 4.009

6. Survivin gene polymorphism association with papillary thyroid carcinoma.

Authors: Nasrin Yazdani; Forough A Sayahpour; Vahid Haghpanah; Parvin Amiri; Maryam Shahrabi-Farahani; Mehran Moradi; Arienne Mirmiran; Mohammad-Taghi Khorsandi; Bagher Larijani; Leila V Mostaan; Mahsa M Amoli
Journal: Pathol Res Pract Date: 2012-01-30 Impact factor: 3.250

7. Thyroid cancer in an iodide rich area: a histopathological study.

Authors: E D Williams; I Doniach; O Bjarnason; W Michie
Journal: Cancer Date: 1977-01 Impact factor: 6.860

8. Ethnic patterns of thyroid cancer incidence in the United States, 1973-1981.

Authors: M R Spitz; J G Sider; R L Katz; E S Pollack; G R Newell
Journal: Int J Cancer Date: 1988-10-15 Impact factor: 7.396

9. Specific microRNAs are downregulated in human thyroid anaplastic carcinomas.

Authors: R Visone; P Pallante; A Vecchione; R Cirombella; M Ferracin; A Ferraro; S Volinia; S Coluzzi; V Leone; E Borbone; C-G Liu; F Petrocca; G Troncone; G A Calin; A Scarpa; C Colato; G Tallini; M Santoro; C M Croce; A Fusco
Journal: Oncogene Date: 2007-06-11 Impact factor: 9.867

6. MicroRNA-6884-5p Regulates the Proliferation, Invasion, and EMT of Gastric Cancer Cells by Directly Targeting S100A16.

Authors: Huifang Lv; Honglin Hou; Huijun Lei; Caiyun Nie; Beibei Chen; Liangyu Bie; Lili Han; Xiaobing Chen
Journal: Oncol Res Date: 2019-12-03 Impact factor: 5.574

6 in total

MicroRNAs networks in thyroid cancers: focus on miRNAs related to the fascin.

1. A pooled analysis of thyroid cancer studies. V. Anthropometric factors.

2. AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. American Association of Clinical Endocrinologists. American College of Endocrinology.

3. The role of microRNA genes in papillary thyroid carcinoma.

4. RAS is regulated by the let-7 microRNA family.

Review 5. microRNA and cancer.

6. Survivin gene polymorphism association with papillary thyroid carcinoma.

7. Thyroid cancer in an iodide rich area: a histopathological study.

8. Ethnic patterns of thyroid cancer incidence in the United States, 1973-1981.

9. Specific microRNAs are downregulated in human thyroid anaplastic carcinomas.

Review 10. MicroRNAs: novel regulators in the hallmarks of human cancer.

Review 1. Molecular mechanisms of long non-coding RNAs in anaplastic thyroid cancer: a systematic review.

2. Antisense-miR-21 enhances differentiation/apoptosis and reduces cancer stemness state on anaplastic thyroid cancer.

3. microRNA-340 influences cell proliferation, apoptosis and invasion by targeting NF-κB1 in gastric cancer.

4. Genetic and epigenetic alterations in differentiated thyroid carcinoma.

5. Genetic and Epigenetic of Medullary Thyroid Cancer

6. MicroRNA-6884-5p Regulates the Proliferation, Invasion, and EMT of Gastric Cancer Cells by Directly Targeting S100A16.